Authors: Miller, Richard K., Washington, Kelli D.
Superior Title: Healthcare Business Market Research Handbook. 2006, p372-375. 4p.
Subject Terms: RESPIRATORY diseases, OBSTRUCTIVE lung diseases, ASTHMA, TUBERCULOSIS
Geographic Terms: UNITED States
Superior Title: PharmaWatch: Monthly Review. Jun2010, Vol. 9 Issue 6, p36-37. 2p.
Subject Terms: *BIOTECHNOLOGY industries, *MERGERS & acquisitions, OBSTRUCTIVE lung diseases, HEPATITIS C, PROTEOLYTIC enzymes
Superior Title: PharmaWatch: Monthly Review. Nov2007, Vol. 6 Issue 11, p18-19. 2p.
Subject Terms: LUNG disease treatment, OBSTRUCTIVE lung diseases, DRUG administration, DRUG development
Geographic Terms: UNITED States
Superior Title: PharmaWatch: Monthly Review. Nov2006, Vol. 5 Issue 11, p27-28. 2p.
Subject Terms: *PHARMACEUTICAL industry, OBSTRUCTIVE lung disease treatment, COMBINATION drug therapy, DRUG therapy for asthma, ANTIASTHMATIC agents
Company/Entity: CHIESI Farmaceutici SpA
Superior Title: PharmaWatch: Monthly Review. Mar2006, Vol. 5 Issue 3, p25-26. 2p.
Subject Terms: OBSTRUCTIVE lung diseases, DISEASES in older people, DYSPNEA, COUGH, BRONCHODILATOR agents, ANTI-inflammatory agents
Geographic Terms: UNITED States
Superior Title: PharmaWatch: Monthly Review. Jan2006, Vol. 5 Issue 1, p27-28. 2p.
Subject Terms: *CONFERENCES & conventions, OBSTRUCTIVE lung diseases, SPECIAL days, CHRONIC diseases, DIAGNOSIS
Company/Entity: WORLD Health Organization
Superior Title: PharmaWatch: Monthly Review. May2010, Vol. 9 Issue 5, p11-11. 1p.
Subject Terms: DRUG approval, OBSTRUCTIVE lung disease treatment
Geographic Terms: UNITED States
Company/Entity: UNITED States. Food & Drug Administration , FOREST Laboratories Inc. FRX, DATAMONITOR Ltd.
Superior Title: PharmaWatch: Monthly Review. Jun2009, Vol. 8 Issue 6, p23-23. 1p.
Subject Terms: OBSTRUCTIVE lung disease treatment, DRUG efficacy
Geographic Terms: EUROPE
Company/Entity: NYCOMED Inc. , EUROPEAN Medicines Agency
Superior Title: PharmaWatch: Monthly Review. Sep2008, Vol. 7 Issue 9, p49-49. 1p.
Subject Terms: *JOINT ventures, CLINICAL drug trials, OBSTRUCTIVE lung disease treatment, DRUG development
Company/Entity: THERAVANCE Inc. THRX, GLAXOSMITHKLINE
Superior Title: Caribbean Business. 7/3/2014, Vol. 42 Issue 25, p25-25. 1/2p.
Subject Terms: OBSTRUCTIVE lung disease treatment
Company/Entity: GLAXOSMITHKLINE , THERAVANCE Inc. THRX
Superior Title: MMR. 11/15/2021, Vol. 38 Issue 13, p59-59. 3/8p. 1 Color Photograph.
Subject Terms: LUNGS, OBSTRUCTIVE lung diseases
Authors: Miller, Richard K.1, Washington, Kelli1
Superior Title: Healthcare Business Market Research Handbook. 2013, p465-466. 2p.
Subject Terms: OBSTRUCTIVE lung diseases, LUNG diseases
Reviews & Products: 2012 Healthcare Business Market Research Handbook, The (Book)
People: MILLER, Richard K., WASHINGTON, Kelli
Superior Title: Chronic Obstructive Pulmonary Disease: Treating Emphysema & Chronic Bronchitis; 2016, preceding p1-41, 43p
Superior Title: Symbicort Case Study: Creating Differentiation in Comination Products; Nov2005, p1-13, 13p
Subject Terms: DRUGS, ANTIASTHMATIC agents, OBSTRUCTIVE lung diseases, PHARMACEUTICAL industry
Company/Entity: ASTRAZENECA PLC
Superior Title: Manager's Legal Bulletin; 3/1/2021, Vol. 35 Issue 5, p1-1, 1/3p
Authors: Simon, Harvey, Zieve, David
Superior Title: Chronic Obstructive Lung Disease Annual Report; 4/8/2008, p1-16, 16p, 1 Chart
Authors: Simon, Harvey
Superior Title: Chronic Obstructive Lung Disease Annual Report; 5/2/2007, p1-16, 16p
Subject Terms: OBSTRUCTIVE lung diseases, BRONCHITIS, PULMONARY emphysema, COUGH, MUCUS, LUNG diseases
Authors: Simon, Harvey
Superior Title: Asthma in Children; 3/26/2007, p1-16, 16p
Subject Terms: ASTHMA in children, ASTHMA, OBSTRUCTIVE lung diseases, RESPIRATORY allergy, ASTHMATICS
Superior Title: Asthma in Children; 2006, p1-16, 16p, 1 Chart
Subject Terms: ASTHMA, OBSTRUCTIVE lung diseases, BRONCHIAL diseases, LUNG diseases, RESPIRATORY allergy
Superior Title: Asthma in Adults; 2006, p1-16, 16p